Yuichi Uwai
Overview
Explore the profile of Yuichi Uwai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uwai Y, Nabekura T
Congenit Anom (Kyoto)
. 2024 Jul;
64(5):207-214.
PMID: 39082936
This pharmacovigilance study investigated the relationship between antiepileptic drugs and congenital strabismus, utilizing the FDA Adverse Event Report System database between 2014 and 2023. Out of 28 347 889 reports...
2.
Uwai Y, Nabekura T
Drugs Real World Outcomes
. 2024 Mar;
11(2):185-193.
PMID: 38556566
Background And Objectives: Clozapine shows higher efficacy against treatment-resistant schizophrenia than other antipsychotics. This study aimed to investigate whether clozapine is associated with the risk of non-hematological malignant tumors, utilizing...
3.
Uwai Y, Nabekura T
Drugs Real World Outcomes
. 2023 Jun;
10(3):481-489.
PMID: 37378859
Background And Objective: Clozapine use is associated with development of neutropenia, and lithium carbonate may be co-administered to reduce this risk; however, this has not yet been adequately investigated. The...
4.
5.
Uwai Y, Nabekura T
J Psychiatr Res
. 2022 Jul;
153:99-103.
PMID: 35810605
The present study attempted to identify risk factors for suicidality and hostility/aggression in patients with bipolar disorders. Data on 3521 patients were extracted from the Japanese Adverse Drug Event Report...
6.
Uwai Y, Nabekura T
Psychiatry Res
. 2022 Jun;
314:114687.
PMID: 35751996
The present study attempted to identify risk factors for Parkinson-like events using the Japanese adverse drug event report database. A total of 3521 patients with bipolar disorders were extracted from...
7.
Uwai Y, Nabekura T
Asian J Psychiatr
. 2021 Sep;
65:102826.
PMID: 34500391
Background: Limited information is currently available on drug overdose in Japan. Therefore, the present study examined drug overdose using the Japanese Adverse Drug Event Report (JADER) database. Methods: The records...
8.
Uwai Y, Nabekura T
Pharmacology
. 2021 May;
106(7-8):446-450.
PMID: 33979799
Lithium, administered to patients of bipolar disorders, is mainly excreted into urine, and tubular reabsorption at the proximal tubule is involved in the renal handling of lithium. In this study,...
9.
Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells
Nabekura T, Kawasaki T, Kato Y, Kawai K, Fiorito S, Epifano F, et al.
Food Funct
. 2020 Jun;
11(6):5017-5023.
PMID: 32530447
P-glycoprotein (encoded by MDR1) is a membrane transport protein expressed in the intestine, liver, kidney, placenta, and blood-brain barrier. It excludes various clinically important drugs from cells, such as verapamil,...
10.
Kawasaki T, Shiozaki Y, Nomura N, Kawai K, Uwai Y, Nabekura T
Pharm Res
. 2020 Jun;
37(6):115.
PMID: 32483763
Purpose: In this study, we investigated organic anion transporting polypeptide 2B1 (OATP2B1)-mediated uptake of fluorescent anions to better identify fluorescent substrates for in vitro OATP2B1 assays. The OATP2B1 is involved...